Joshua D. Brown

4.1k total citations
183 papers, 2.8k citations indexed

About

Joshua D. Brown is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joshua D. Brown has authored 183 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Public Health, Environmental and Occupational Health, 31 papers in Pediatrics, Perinatology and Child Health and 30 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joshua D. Brown's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Joshua D. Brown is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Joshua D. Brown collaborates with scholars based in United States, United Kingdom and Sweden. Joshua D. Brown's co-authors include Almut G. Winterstein, Jeffery Talbert, Amie Goodin, Patrick M. O’Neil, Anand R. Shewale, Val R. Adams, Chenghui Li, Shawn Michelle Smith, Bradley C. Martin and Nathan Pauly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Neurology.

In The Last Decade

Joshua D. Brown

172 papers receiving 2.7k citations

Peers

Countries citing papers authored by Joshua D. Brown

Since Specialization

Citations

This map shows the geographic impact of Joshua D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua D. Brown more than expected).

Fields of papers citing papers by Joshua D. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua D. Brown. The network helps show where Joshua D. Brown may publish in the future.

Co-authorship network of co-authors of Joshua D. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua D. Brown. A scholar is included among the top collaborators of Joshua D. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua D. Brown. Joshua D. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Successful Treatment of a Case of Flecainide-induced Ventricular Tachycardia Secondary to Acute Kidney Injury 2025 ·American Journal of Respiratory and Critical Care Medicine ·Mohammed Farrag, (unknown), Joshua D. Brown, Andrew Stokes, (unknown), (unknown)	0
2	Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry 2024 ·Pharmacoepidemiology and Drug Safety ·Vicki Osborne, Amie Goodin, Joshua D. Brown, Almut G. Winterstein, Andrew Bate, Catherine Cohet, Lisa Pont, David Moeny, Olaf H. Klungel, Simone Pinheiro, John D. Seeger, K. Arnold Chan, Stanley A. Edlavitch, Hugh H. Tilson, Deborah Layton	0
3	Association between low cognitive performance and diabetes‐related health indicators across racial and ethnic groups in adults with diabetes 2024 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), Joshua D. Brown, Yichen Zhang, (unknown), Jingchuan Guo, Guillermo E. Umpierrez, K.M. Venkat Narayan, Ambar Kulshreshtha, Francisco J. Pasquel, Mohammed K. Ali, Hui Shao	1
4	Incident mental health episodes after initiation of gabapentinoids vs. dopamine agonists for early-onset idiopathic restless legs syndrome 2023 ·Psychiatry Research ·(unknown), Scott Martin Vouri, Joshua D. Brown, Barry Setlow, Amie Goodin	4
5	Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US 2023 ·JAMA Network Open ·Yehua Wang, Larisa H. Cavallari, Joshua D. Brown, Cameron D. Thomas, Almut G. Winterstein	9
6	Incremental burden on health‐related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non‐institutionalized people with diabetes aged 65 years and older 2023 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), (unknown), Yichen Zhang, Ping Zhang, Shichao Tang, Joshua D. Brown, Jingchuan Guo, Yongkang Zhang, Hui Shao	3
7	Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Stephan Schmidt, Valvanera Vozmediano, Rodrigo Cristofoletti, Sarah Kim, Zhoumeng Lin, Natália Valadares de Moraes, (unknown), Brian Cicali, Hans Leuenberger, Joshua D. Brown, Jin Y. Jin, Cynthia J. Musante, Stacey Tannenbaum, Yaning Wang	4
8	Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine–Topiramate to Prevent Exposure During Pregnancy 2023 ·Annals of Internal Medicine ·Amir Sarayani, William T. Donahoo, Christian Hampp, Joshua D. Brown, Almut G. Winterstein	4
9	Associations Between Postdischarge Care and Cognitive Impairment–Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes 2023 ·Diabetes Care ·Yehua Wang, (unknown), (unknown), Joshua D. Brown, Jingchuan Guo, Ambar Kulshreshtha, Yongkang Zhang, Almut G. Winterstein, Hui Shao	1
10	Newer glucose‐lowering drugs and risk of dementia: A systematic review and meta‐analysis of observational studies 2023 ·Journal of the American Geriatrics Society ·Huilin Tang, Hui Shao, C. Elizabeth Shaaban, Keming Yang, Joshua D. Brown, Stephen D. Anton, Yonghui Wu, Adam P. Bress, William T. Donahoo, Steven T. DeKosky, Jiang Bian, Jingchuan Guo	60
11	Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression 2022 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Raj Desai, Haesuk Park, Joshua D. Brown, Rajesh Mohandas, Steven M. Smith	3
12	Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare 2022 ·Diabetes Care ·Hui Shao, (unknown), Jingchuan Guo, (unknown), Yongkang Zhang, Jing Luo, Lizheng Shi, Vivian Fonseca, Joshua D. Brown	10
13	Risk of Obstructive Sleep Apnea in Adults with Resistant Hypertension 2022 ·MDPI (MDPI AG) ·Raj Desai, Haesuk Park, Joshua D. Brown, Steven M. Smith	1
14	Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension 2022 ·Hypertension ·Raj Desai, Haesuk Park, Joshua D. Brown, Rajesh Mohandas, Carl J. Pepine, Steven M. Smith	8
15	Reliability and Validity of the Short-Form 12 Item Version 2 (SF−12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population 2020 ·Journal of Clinical Medicine ·(unknown), Joshua D. Brown	41
16	Impact of opioid dose escalation on pain intensity: a retrospective cohort study 2020 ·Pain ·Corey J. Hayes, Erin E. Krebs, Teresa J. Hudson, Joshua D. Brown, Chenghui Li, Bradley C. Martin	16
17	Patients' reasons for weight loss and their relations to clinical weight loss outcomes in a comprehensive lifestyle intervention 2019 ·Obesity Science & Practice ·Leah Boepple, Ian Cero, Ryan J. Marek, Sandra M. Coulon, Janet A. Lydecker, Joshua D. Brown, Robert Malcolm, Patrick M. O’Neil	4
18	Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (LIFE) Study 2019 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Marco Pahor, Todd M. Manini, Joshua D. Brown	0
19	Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention 2017 ·Obesity ·Ryan J. Marek, Sandra M. Coulon, Joshua D. Brown, Janet A. Lydecker, Scott Marek, Robert Malcolm, Patrick M. O’Neil	14
20	The Power and Pitfalls of Big Data Research in Obstetrics and Gynecology: A Consumer's Guide 2017 ·Obstetrical & Gynecological Survey ·Amie Goodin, Chris Delcher, (unknown), Xi Wang, Yanmin Zhu, Dikea Roussos‐Ross, Joshua D. Brown	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact